Bifogade filer
Kurs
0,00%
Likviditet
2,30 MNOK
Kalender
Tid* | ||
2026-02-12 | 07:30 | Bokslutskommuniké 2025 |
2025-11-06 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | 07:00 | Kvartalsrapport 2025-Q1 |
2025-04-24 | N/A | X-dag ordinarie utdelning ULTI 0.00 NOK |
2025-04-23 | N/A | Årsstämma |
2025-01-31 | - | Bokslutskommuniké 2024 |
2025-01-09 | - | Extra Bolagsstämma 2025 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-04-25 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2024-04-24 | - | Årsstämma |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-11-08 | - | Kvartalsrapport 2023-Q3 |
2023-08-22 | - | Kvartalsrapport 2023-Q2 |
2023-05-10 | - | Kvartalsrapport 2023-Q1 |
2023-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2023-04-20 | - | Årsstämma |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-11-10 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2022-04-20 | - | Årsstämma |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-08-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-04-22 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2021-04-21 | - | Årsstämma |
2021-02-17 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-11-11 | - | Extra Bolagsstämma 2020 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-04-16 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2020-04-15 | - | Årsstämma |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
Oslo, 21 April 2022: Ultimovacs ASA held its annual general meeting today 21 April 2022. All the matters on the agenda were approved.
All board members were re-elected for a period of one year, and the Board of Directors will continue to consist of the following persons:
- Jónas Einarsson, Chair of the Board
- Kari Grønås, board member
- Eva S. Dugstad, board member
- Leiv Askvig, board member
- Ketil Fjerdingen, board member
- Henrik Schüssler, board member
- Aitana Peire, board member
- Haakon Stenrød, board member
Håkan Englund as Deputy Board Member was not up for election, and will consequently retire from this position.
The Nomination Committee is unchanged up until the Annual General Meeting in 2023, and the Nomination Committee will continue to consist of the following persons:
- Ole Kristian Hjelstuen, Chair of the committee
- Hans Peter Bøhn
- Jakob Iqbal
The minutes from the meeting are enclosed and available at the company’s website.
For further information, please see www.ultimovacs.com or contact:
Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815